Snap Inc’s recent IPO gives us a golden opportunity to examine the tenets of value investing. To much fanfare, Snapchat (as I’ll refer to the company in the rest of this article) went public last week. During its first week of trading it jumped to a high of $28.84 and today is trading around $25 a share. That gives Snapchat a valuation of about $32 billion. (Update: Between writing this....More>>>
It’s been a busy week for the folks at Patriot One Technologies (OTCQB: PTOTF) (TSX VENURE: PAT.V), and the way the stock is moving this morning, it doesn’t look like anyone is going to be leaving early today to get a jump on the weekend, either. On Tuesday of this week Patriot One announced a big bump in sales over the past three months of their award winning PATSCAN....More>>>
Investment company Watermark Asset Management, Inc. buys , iShares 7-10 Year Treasury Bond ETF, Amgen Inc, , iShares Core Aggressive Allocation, Barclays Bank PLC, iShares Core Moderate Allocation, iShares MSCI KLD 400 Social, Five Point Holdings LLC, Micro Focus International PLC, sells Vanguard Total Stock Market, iShares J.P. Morgan USD Emerging Markets Bond ETF, Vanguard Energy, VanEck Vectors....More>>>
The US financial sector has been on a solid run of late. Over the last 12 months the S&P 500 Financials Sector has returned 18.9% relative to the S&P 500 Index of 17.9%. Many analysts have formed the view that with the potential for higher market interest rates, this sector has a long runway ahead. So with this in mind I thought that it would be a good time to update my estimates of the....More>>>
Although several obesity drugs are now on the market, they haven’t caught on nearly as much as biopharmaceutical companies had hoped they would. Investors looking to buy obesity-drug stocks are better off finding companies that also have other products either on the market or in development.
Eisai (NASDAQOTH:ESALY), Novo Nordisk (NYSE:NVO), and Roche Holding Ltd. (NASDAQOTH:RHHBY) fit....More>>>